DOWNERS GROVE, Ill., June 1, 2017 /CNW/ -- Univar Canada Ltd., a subsidiary of Univar Inc. (NYSE: UNVR) ("Univar"), a global chemical and ingredient distributor and provider of value-added services, is proud to announce a relationship with Innophos Inc., in which Univar will be the exclusive provider of Innophos' specialty portfolio of botanical and dietary enzyme ingredients for the nutritional markets nationwide in Canada.
"We are delighted to bring to the Canadian market these unique and specialized premium botanicals and enzymes, which address the performance-critical needs of the natural health formulating community," said Willy St. Cyr, vice president of product and industry development and sales operations for Univar Canada. "Innophos ingredients are backed by science, quality and applications expertise. Coupled with our value-added services and the breadth of our distribution network, this strategic alliance allows Univar Canada to build on our health benefits platform offerings to customers who specialize in end markets that include sports performance supplementation, healthy aging and digestive health."
"We are excited to partner with Univar to deliver our specialty ingredient solutions to the Canadian food, health and nutrition markets," added Sherry Duff, senior vice president, chief marketing & technology officer of Innophos Inc. "Innophos' botanical and dietary enzyme ingredients allow manufacturers to develop functional products that respond to a wide range of growing consumer demands. From our innovative CranSmart® PAC blend, which enables manufacturers to deliver whole cranberry benefits for urinary tract health in one small capsule or tablet, to our recently released ChelaMax®, which supports the inclusion of minerals in on-the-go delivery forms where taste is critical, we are committed to providing science-backed, vital ingredient solutions that help manufacturers differentiate their products and deliver value to the end consumer."
Founded in 1924, Univar Inc. (NYSE: UNVR), is a global chemical and ingredients distributor and provider of value-added services, working with leading suppliers worldwide. Supported by a comprehensive team of sales and technical professionals with deep specialty and market expertise, Univar operates hundreds of distribution facilities throughout North America, Western Europe, Asia-Pacific and Latin America. Univar delivers tailored customer solutions through a broad product and services portfolio sustained by one of the most extensive industry distribution networks in the world. For more information, visit www.univar.com.
About Innophos Inc.
Innophos Inc. is a manufacturer and distributor of bioactive mineral ingredients, unique enzyme formulations, premium botanical ingredients, and specialty blends into the nutritional natural products industries worldwide. Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. Innophos leverages its expertise in the science and technology of blending and formulating phosphate, mineral and botanical based ingredients to help customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information please visit www.innophosnutrition.com and www.innophos.com.
Safe Harbor for Forward-Looking and Cautionary Statements from Innophos
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks, including those risks identified under "Risk Factors" in Innophos' Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.
For further information: Univar Inc., Media Relations, +1 331-777-6176, firstname.lastname@example.org; Innophos Holdings, Inc., Mark Feuerbach: (609) 366-1204, Investor.email@example.com; Sharon Merrill Associates, Ryan Flaim (617) 542-5300, IPHS@investorrelations.com, http://www.univar.com/